Fig. 7
Natural targeting of various cells by LNP-RNA therapeutics influenced by PEG-lipid shedding and protein corona composition. ApoE, high-density lipoprotein (HDL), vitronectin, and albumin can naturally target LNPs to the liver parenchyma, lymphatic vessel, and tumor and breast cancer cells, respectively